Dear Editor,
We are grateful that Davis et al. chose to share the anaesthetic management of patients undergoing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) at Waikato Hospital in New Zealand. It was encouraging to read that they are achieving low mortality rates and are able to limit the volume of intraoperative intravenous fluid administered.
At Princess Alexandra Hospital, our standard practice has changed somewhat since the published data were collected (between July 2009 and July 2015). Previously, the cases went on for longer and patients were profoundly coagulopathic, so epidural analgesia was avoided. The benefits of using epidural analgesia described by Davis et al. have also been demonstrated in previous studies. 1, 2 Since the start of 2017, we have routinely used thoracic epidural anaesthesia unless otherwise contraindicated.
The findings of our audit did not demonstrate any significant differences in the incidence of postoperative acute kidney injury between patients who received >15 L and those who received <15 L of intraoperative intravenous fluid. 3 Furthermore, we found that our patients received a greater average volume of intraoperative fluid than in other studies. 4, 5 We have now moved towards lower volume intra-operative intravenous fluid administration strategies to avoid excessive tissue oedema in the post-operative period. We aim to tailor fluid administration to achieve a urine output of at least 1 ml/kg/h. In addition, fluid losses due to bowel preparation, fasting and evaporation from an open abdomen, as well as daily maintenance fluid requirements, need to be accounted for. Further intravenous fluids and vasopressors are administered, as required, to maintain endorgan perfusion and reduce the risk of renal failure.
The majority of our patients are stable enough to be extubated at the end of the procedure. However, the intensive care unit (ICU) at Princess Alexandra Hospital prefers to have these patients ventilated and has specifically asked for patients to remain intubated. Some of these patients develop systemic inflammatory response syndrome in the immediate post-operative period and require vasopressor support to maintain their haemodynamics. Therefore, we prefer to monitor these patients for a few hours in the ICU to ensure that they are stable before extubation. This explains the relatively low proportion of patients that were extubated in theatre in our audit compared to Davis et al. and other previous studies. 1, 2 In conclusion, the anaesthetic management of patients undergoing CRS with HIPEC at Princess Alexandra Hospital in Brisbane, Queensland, has changed since the findings of our audit were published. In line with other international centres practising CRS with HIPEC, 2 we routinely employ the use of thoracic epidural analgesia. We have a far less liberal intraoperative intravenous fluid administration strategy than previously described and, as per our local ICU guidelines, the majority of our patients are transferred to the ICU intubated and ventilated at the end of the procedure.
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